iTakeControl
- Websites:
- https://casimir.itakecontrolhealth.com/
- https://inozyme.itc-portal.com/
- https://neurogene.itc-portal.com/
- https://regenxbio.itakecontrolhealth.com
- https://solidbio.itc-portal.com
- https://regenxbio.itc-portal.com/
- https://aviditydmd.itc-portal.com
- https://pfizer.itc-portal.com/
- https://ionis.itc-portal.com
- https://worldwide80067310.itc-portal.com/
- Users:
- 12,609 (Average 450 / extension)
- Emails:
- he*****@itakecontrolhealth.com,av*****@itakecontrolhealth.com
- Rating:
- 0.00 (0)
- Total published:
- 28
Published Android apps:
28 results. Page 1 of 2.
This is a mobile app in support of the Alpha Study.
This is a mobile app in support of the REVEAL Study
This is a mobile app in support of the RESONANCE Study.
This is a mobile app in support of the ARISE Study.
This is a mobile app in support of the INZ ENERGY 3 Study.
This is a mobile app in support of the Alpha-3 Study
This is a mobile app in support of the DELIVER DVA Study.
This is a mobile app in support of the RGX 121-5101 Study.
This is a mobile app in support of the AIRI Study.
This is a mobile app in support of the REACH CDM X Study.
This is a mobile app in support of the Neurogene Study
This is a mobile app in support of the EMPEROR-Study
This is a mobile app in support of the RGX 121-1102 Study.
This is a mobile app in support of the Solid Bio Study
This is a mobile app in support of the RGX 121-101 Study.
This is a mobile app in support of the EXPLORE44-OLE Study.
This is a mobile app in support of the NSAA Pilot Study.
This is a mobile app in support of the REVEAL Pediatric Study
This is a mobile app in support of the Lotus Study
This is a mobile app in support of the Ionis Reveal Study
This is a mobile app in support of the Embolden™ Study Home Videos Study
This is a mobile app in support of the MARINA-OLE Study.
This is a mobile app in support of the Insmed Study
This is a mobile app in support of the IMPACT DVA Study
This is a mobile app in support of the Tern Therapeutics Study
28 results. Page 1 of 2.